B Delia Johnson

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

Carl J Pepine, Arshed A Quyyumi, Amir Lerman, 2006, Journal of the American College of Cardiology.

Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)

Carl J Pepine, Saibal Kar, Bruce Samuels, 2019, Journal of interventional cardiology.

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Carl J Pepine, C Noel Bairey Merz, S. Reis, 2010, Journal of the American College of Cardiology.

Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.

Debiao Li, Carl J Pepine, Daniel S Berman, 2015, Circulation. Cardiovascular imaging.

Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.

Carl J Pepine, C Noel Bairey Merz, L. Shaw, 2013, American heart journal.

Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.

Carl J Pepine, Morton F Arnsdorf, Issam Zineh, 2009, Archives of internal medicine.